Western Luke F, Diana Giovanni, Praveen Prav, Ho Michael W, Dhanda Jagtar, Tighe David, Bowe Conor, Holden Adam, Barsaiyan Gaurav, McMahon Jeremy, El Kininy Walid, Doumas Stergios N
East Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom; King's College London, London, United Kingdom.
Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Br J Oral Maxillofac Surg. 2025 Sep;63(7):534-540. doi: 10.1016/j.bjoms.2025.04.007. Epub 2025 Jun 6.
Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with a propensity for lymphatic spread, particularly to the neck. There are current inconsistencies in the treatment paradigm for cT3/4 OSCC with negative nodal status. The American Society of Clinical Oncology (ASCO) recent guidelines advocate for contralateral neck treatment with neck dissection or radiotherapy, but this approach remains debated and has not been adopted within UK clinical guidance. This study aims to evaluate the recurrence rates and survival outcomes of patients with well lateralised pT3/4N0 OSCC managed with or without contralateral neck interventions. A retrospective cohort study was conducted across five UK Oral and Maxillofacial Surgery (OMFS) units. We included patients with biopsy-proven pT3/T4 OSCC treated between 2012 and 2017. The study compared outcomes between two groups: the standard care group (SC) and the extended neck management group (ENM), which additionally received contralateral neck dissection (CLND) or neck radiotherapy (NRT). The primary outcome measure was the recurrence rate (RR), with secondary outcome measures including overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS). Of 583 patients, 210 met the inclusion criteria. The mean follow up was 44 months. The SC group, compared with ENM demonstrated similar overall recurrence rate (24.8% vs 24.6%), higher regional recurrence (7.4% vs. 1.6%) and lower distant recurrence rates (4% vs 6.6%) respectively, however, none of these results reached significance. No significant differences in OS, DFS, or RFS were demonstrated (p > 0.05) between groups, and this was maintained with confounding variables controlled for. Findings suggest that well lateralised T3/4N0 OSCC patients managed more conservatively, without contralateral neck intervention, may have comparable outcomes to those receiving additional neck management. Further research into this area of research paucity may assist in further refinement of management guidelines for this subset of OSCC patients.
口腔鳞状细胞癌(OSCC)是一种常见的恶性肿瘤,具有淋巴转移倾向,尤其是颈部转移。目前,cT3/4期且淋巴结阴性的OSCC治疗模式存在不一致之处。美国临床肿瘤学会(ASCO)最近的指南主张对侧颈部进行治疗,包括颈部清扫术或放疗,但这种方法仍存在争议,尚未被纳入英国临床指南。本研究旨在评估接受或不接受对侧颈部干预的pT3/4N0期OSCC患者的复发率和生存结果。在英国五个口腔颌面外科(OMFS)单位进行了一项回顾性队列研究。我们纳入了2012年至2017年间经活检证实为pT3/T4期OSCC的患者。该研究比较了两组的结果:标准治疗组(SC)和扩大颈部管理组(ENM),后者还接受了对侧颈部清扫术(CLND)或颈部放疗(NRT)。主要结局指标是复发率(RR),次要结局指标包括总生存期(OS)、无病生存期(DFS)和无复发生存期(RFS)。583例患者中,210例符合纳入标准。平均随访时间为44个月。与ENM组相比,SC组的总体复发率相似(24.8%对24.6%),区域复发率更高(7.4%对1.6%),远处复发率更低(4%对6.6%),然而,这些结果均无统计学意义。两组之间在OS、DFS或RFS方面均未显示出显著差异(p>0.05),在控制混杂变量后这一结果仍然成立。研究结果表明,对于pT3/4N0期OSCC患者,采用更保守的治疗方式,不对对侧颈部进行干预,可能与接受额外颈部管理的患者具有相似的结局。对这一研究匮乏领域的进一步研究可能有助于进一步完善该亚组OSCC患者的管理指南。